PathAI CEO recently shared his thoughts about the future of #AI and #clinicaldevelopment. Meet our wonderful CEO and get to know more about Andy's journey!
PathAI CEO, Andrew Beck was recently quoted in the #AACR journal #CancerDiscovery, discussing #foundationmodels in pathology. As quoted, Andy shares how the effectiveness of #AI tools in #pathology depends on the infrastructure and implementation surrounding them; also sharing that most valuable tools are those that are well-integrated into clinical workflows, aiding decision-making and reducing clinician workload. Andy is a trained pathologist and in 2016 he founded PathAI with the vision of transforming #digitalpathology by utilizing the latest AI tools to enable more efficient pathology workflows and reduce the workload of pathologists to transform #drugdevelopment, #diagnostics, and more. Read more about Andy and our mission at PathAI: https://lnkd.in/eWhhgwZW